| Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. DE Gomez, DF Alonso, H Yoshiji, UP Thorgeirsson European journal of cell biology 74 (2), 111-122, 1997 | 2278 | 1997 |
| Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer H Yoshiji, DE Gomez, M Shibuya, UP Thorgeirsson Cancer Research 56 (9), 2013-2016, 1996 | 546 | 1996 |
| Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model H Yoshiji, S Kuriyama, Y Miyamoto, UP Thorgeirsson, DE Gomez, ... Hepatology 32 (6), 1248-1254, 2000 | 377 | 2000 |
| Ras oncogene mediated induction of a 92kDa metalloproteinase; strong correlation with the malignant phenotype M Ballin, DE Gomez, CC Sinha, UP Thorgeirsson Biochemical and Biophysical Research Communications 154 (3), 832-838, 1988 | 255 | 1988 |
| Deregulation of the signaling pathways controlling urokinase production: its relationship with the invasive phenotype JA Aguirre Ghiso, DF Alonso, EF Farías, DE Gomez, E Bal de Kier Joffè European journal of biochemistry 263 (2), 295-304, 1999 | 243 | 1999 |
| Telomere structure and telomerase in health and disease DE Gomez, RG Armando, HG Farina, PL Menna, CS Cerrudo, ... International journal of oncology 41 (5), 1561-1569, 2012 | 237 | 2012 |
| Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer HG Farina, M Pomies, DF Alonso, DE Gomez Oncology reports 16 (4), 885-891, 2006 | 197 | 2006 |
| The copper‐chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells J Yoshii, H Yoshiji, S Kuriyama, Y Ikenaka, R Noguchi, H Okuda, ... International journal of cancer 94 (6), 768-773, 2001 | 188 | 2001 |
| Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis DF Alonso, HG Farina, G Skilton, MR Gabri, MS De Lorenzo, DE Gomez Breast cancer research and treatment 50, 83-93, 1998 | 176 | 1998 |
| Mammary carcinoma cells over‐expressing tissue inhibitor of metalloproteinases‐1show vascular endothelial growth factor expression H Yoshiji, SR Harris, E Raso, DE Gomez, CK Lindsay, M Shibuya, ... International journal of cancer 75 (1), 81-87, 1998 | 166 | 1998 |
| Irreversible telomere shortening by 3′-azido-2′, 3′-dideoxythymidine (AZT) treatment DE Gomez, AM Tejera, OA Olivero Biochemical and biophysical research communications 246 (1), 107-110, 1998 | 140 | 1998 |
| CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo SE Perea, O Reyes, I Baladron, Y Perera, H Farina, J Gil, A Rodriguez, ... Molecular and cellular biochemistry 316, 163-167, 2008 | 126 | 2008 |
| Cancer vaccines: an update with special focus on ganglioside antigens RJ Bitton, MD Guthmann, MR Gabri, AJL Carnero, DF Alonso, L Fainboim, ... Oncology Reports 9 (2), 267-276, 2002 | 125 | 2002 |
| Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells HG Farina, DR Bublik, DF Alonso, DE Gomez Clinical & experimental metastasis 19, 551-560, 2002 | 123 | 2002 |
| Tumor invasion, proteolysis, and angiogenesis UP Thorgeirsson, CK Lindsay, DW Cottam, DE Gomez Brain Tumor Invasiveness, 1-15, 1994 | 113 | 1994 |
| Rho GTPases as therapeutic targets in cancer G Cardama, N Gonzalez, J Maggio, P Lorenzano Menna, DE Gomez International Journal of Oncology 51 (4), 1025-1034, 2017 | 105 | 2017 |
| NGcGM3 ganglioside: a privileged target for cancer vaccines LE Fernandez, MR Gabri, MD Guthmann, RE Gomez, S Gold, L Fainboim, ... Journal of Immunology Research 2010 (1), 814397, 2010 | 104 | 2010 |
| New drugs are not enough-drug repositionin in oncology: An update R Armando, D Mengual Gomez, DE Gomez International Journal of Oncology, 2020 | 90 | 2020 |
| Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines G A Cardama, M J Comin, L Hornos, N Gonzalez, L Defelipe, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2014 | 87 | 2014 |
| Temporal and topographic matrix metalloproteinase expression after vascular injury in mice HR Lijnen, F Lupu, L Moons, P Carmeliet, D Goulding, D Collen Thrombosis and haemostasis 81 (05), 799-807, 1999 | 85 | 1999 |
Daniel F. AlonsoFull Professor, National University of Quilmes; Principal Researcher, CONICET (Argentina)在 unq.edu.ar 的电子邮件经过验证
